Our U.S. patient assistance programs help make Gilead therapies accessible for uninsured individuals and those who need financial assistance.
Support Path™ assists eligible hepatitis C patients in the United States access Sovaldi® (sofosbuvir) or Harvoni® (ledipasvir/sofosbuvir). The program consists of an integrated offering of support services for patients and providers, among them:
A call center staffed with associates trained to help patients and their providers with insurance-related needs.
Education and support, including a 24/7 nursing support service line.
The Sovaldi and Harvoni Co-pay Coupon Programs, which provide co-pay assistance for eligible patients with private insurance who need assistance paying for their out-of-pocket medication costs.
Education and support, including a 24/7 nursing support service line.
The Sovaldi and Harvoni Co-pay Coupon Programs, which provide co-pay assistance for eligible patients with private insurance who need assistance paying for their out-of-pocket medication costs.
Most patients will pay no more than $5 per co-pay.
The Support Path Patient Assistance Program will provide Sovaldi and Harvoni at no charge for eligible patients with no other insurance options.
The Support Path Patient Assistance Program will provide Sovaldi and Harvoni at no charge for eligible patients with no other insurance options.
To learn more about Support Path for Sovaldi® and Harvoni®, please call 1-855-769-7284, Monday through Friday between 9:00 a.m. and 8:00 p.m. (Eastern Time).
Harvoni (ledipasvir and sofosbuvir)
Gilead has published both U.S. Prescribing Information and Patient Information, on their support website.
In addition check out HCV Advocates new factsheet for; Genotype 1:Treatment: Harvoni (Sofosbuvir & Ledipasvir), other factsheets include; Sovaldi: Genotype 1 Triple Therapy, Sovaldi: Genotype 2 & 3 and Sovaldi: Genotype 4 Triple Therapy
In case you missed it; HCV Newsetters: Everything you need to know about Gilead's Harvoni
In addition check out HCV Advocates new factsheet for; Genotype 1:Treatment: Harvoni (Sofosbuvir & Ledipasvir), other factsheets include; Sovaldi: Genotype 1 Triple Therapy, Sovaldi: Genotype 2 & 3 and Sovaldi: Genotype 4 Triple Therapy
In case you missed it; HCV Newsetters: Everything you need to know about Gilead's Harvoni
I want to thank gilead for saving my son's life..he is 54 years old, mentally challenged, has emphysema which has progressed to COPD...oxygen 24hrs a day....it was not discovered (hep c) until a test was done on his liver...to finally see why so much bruising..4th stage cirrhosis of the liver!...we appealed to gilead and he was accepted to receive treatment..blood tests showed several months after start of treatment, hep c was gone. his financial situation was he receives from SSI. obviously, he could not receive the benefit of this wonderful treatment without the interest and kindness shown us before and during the treatment. so grateful...thank you again for my son's life to extend....this is a wondrous thing!
ReplyDelete